The inhibitory effect of endostatin and doxycycline administration on B16 melanoma angiogenesis and cellular proliferation

[1]  Hua Guo,et al.  [Study on the molecular mechanism of endostatin and doxycycline in suppressing melanoma growth]. , 2006, Zhonghua bing li xue za zhi = Chinese journal of pathology.

[2]  S. Tejpar,et al.  Assessment of endostatin gene therapy for familial adenomatous polyposis-related desmoid tumors. , 2006, Cancer research.

[3]  C. Addison,et al.  The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix. , 2006, Experimental cell research.

[4]  G. Hou,et al.  Doxycycline alters vascular smooth muscle cell adhesion, migration, and reorganization of fibrillar collagen matrices. , 2006, The American journal of pathology.

[5]  J. S. Gutkind,et al.  Rapid development of salivary gland carcinomas upon conditional expression of K-ras driven by the cytokeratin 5 promoter. , 2006, The American journal of pathology.

[6]  Jennifer S. Lin,et al.  Inhibition of human nasopharyngeal carcinoma growth and metastasis in mice by adenovirus-associated virus–mediated expression of human endostatin , 2006, Molecular Cancer Therapeutics.

[7]  R. Fleischmajer,et al.  Tetracyclines: nonantibiotic properties and their clinical implications. , 2006, Journal of the American Academy of Dermatology.

[8]  D. Schuppan,et al.  Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans. , 2005, Biochemical and biophysical research communications.

[9]  K. Alitalo,et al.  An Endostatin-derived Peptide Interacts with Integrins and Regulates Actin Cytoskeleton and Migration of Endothelial Cells* , 2004, Journal of Biological Chemistry.

[10]  T. Salo,et al.  Endostatin Inhibits Human Tongue Carcinoma Cell Invasion and Intravasation and Blocks the Activation of Matrix Metalloprotease-2, -9, and -13* , 2003, Journal of Biological Chemistry.

[11]  M. Hendrix,et al.  Targeting the Tumor Microenvironment with Chemically Modified Tetracyclines: Inhibition of Laminin 5 γ2 Chain Promigratory Fragments and Vasculogenic Mimicry1Supported by NIH/National Cancer Institute Grants CA83137 (to R. E. B. S.), CA80318, CA88043-02S1, and CA59702 (to M. J. C. H.).1 , 2002 .

[12]  J. Folkman.  Angiogenesis: an organizing principle for drug discovery? , 2007, Nature reviews. Drug discovery.

[13]  Wenlin Huang,et al.  [Inhibition of tongue cancer development in nude mice transfected with adenovirus carrying human endostatin gene]. , 2003, Ai zheng = Aizheng = Chinese journal of cancer.

[14]  M. Hendrix,et al.  Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicry. , 2002, Molecular cancer therapeutics.